Keyphrases
Mutant Mice
100%
Prostate
100%
NKX3.1
100%
Epithelial Ingrowth
100%
Antioxidant Therapy
100%
Prostate Cancer
37%
Vitamin E
37%
Antioxidant
37%
N-acetylcysteine
37%
Cancer Prevention
25%
Prevention Trials
25%
Reactive Oxygen Species
25%
Selenium
25%
Epithelial Cell Proliferation
25%
Dysplasia
25%
Gene Signature
12%
Genetic Risk
12%
Reactive Oxygen Species Level
12%
Causal Factors
12%
Prostate Tumorigenesis
12%
Published Data
12%
Prostate Cancer Risk
12%
Homeobox Genes
12%
Cancer Formation
12%
Cancer Initiation
12%
Prostate Epithelial Cells
12%
Loss of Expression
12%
Tumorigenicity
12%
Pre-clinical and Clinical Trials
12%
Accurate Model
12%
Epithelial Hyperplasia
12%
Inhibits Proliferation
12%
Pro-proliferative
12%
Prostatic Hyperplasia
12%
Discrepant Results
12%
Mouse Prostate
12%
Prostate Cancer Chemoprevention
12%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Mutant
100%
Antioxidant
100%
Prostate Cancer
71%
Malignant Neoplasm
42%
Reactive Oxygen Metabolite
42%
Alpha Tocopherol
42%
N-Acetylcysteine
42%
Dysplasia
28%
Preclinical Study
14%
Clinical Trial
14%
Genetic Risk
14%
Carcinogenicity
14%
Prostate Hypertrophy
14%
Epithelium Hyperplasia
14%
Carcinogenesis
14%
Transcription Factors
14%
Diseases
14%
Medicine and Dentistry
Antioxidant
100%
Prostate Cancer
71%
Alpha Tocopherol
42%
Reactive Oxygen Species
42%
N-Acetylcysteine
42%
Epithelial Cell
28%
Cell Proliferation
28%
Dysplasia
28%
Cancer Prevention
28%
Genetic Risk Factor
14%
Cancer Risk
14%
Carcinogenesis
14%
Malignant Neoplasm
14%
Carcinogenicity
14%
Prostate Hypertrophy
14%
Epithelium Hyperplasia
14%
Clinical Trial
14%
Chemoprevention
14%
Transcription Factors
14%
Homeobox
14%
Diseases
14%
Biochemistry, Genetics and Molecular Biology
Mouse Mutant
100%
Acetylcysteine
75%
Vitamin E
75%
Dysplasia
50%
Cell Proliferation
50%
Gene Signature
25%
Homeobox
25%
Clinical Trial
25%
Genetic Risk
25%
Preclinical Study
25%
Transcription Factors
25%
Carcinogenesis
25%
Immunology and Microbiology
Prostate
100%
Mouse Mutant
100%
Vitamin E
50%
Cell Proliferation
33%
Preclinical Study
16%
Genetic Risk
16%
Transcription Factors
16%
Homeobox
16%